Association of the Apollo Wearable With Fatigue, Raynaud Phenomenon, and Quality of Life in Patients With Systemic Sclerosis: A Pilot Study
Use of the Apollo wearable for 4 weeks was associated with improvement in fatigue and RP symptoms in patients with SSc, with improved QOL measures, lower depression scores, and improved disability measures. Future studies should further test the efficacy of the Apollo wearable in these domains and QOL of patients with SSc. (ClinicalTrials.gov: NCT04854850).
Authors
- Yongseok Park (ORCID: https://orcid.org/0000-0002-2058-6833)
- Robert Lafyatis (ORCID: https://orcid.org/0000-0002-9398-5034)
- Maureen Laffoon
- Haomin Hu (ORCID: https://orcid.org/0000-0001-9200-062X)
- Robyn T. Domsic (ORCID: https://orcid.org/0000-0002-2765-0922)
- Krista Hammaker
- Leigh A. Freno
Institutions
- University of Pittsburgh (US)
- Robert Morris University (US)
- University Ucinf (CL)
- Center for Rheumatology (US)
- La Roche College (US)
- Northeast Ohio Medical University (US)
Publication Details
- Journal
- The Journal of Rheumatology
- Published
- 2024-12-01
- DOI
- https://doi.org/10.3899/jrheum.2024-0551
- Citations
- 1
- Primary Topic
- Systemic Sclerosis and Related Diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.42